DON LYNN GIBBONS to Mesothelioma
This is a "connection" page, showing publications DON LYNN GIBBONS has written about Mesothelioma.
Connection Strength
0.123
-
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma. Oncologist. 2020 10; 25(10):e1457-e1463.
Score: 0.123
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.